Nyxoah S.A. (NASDAQ:NYXH) Receives Average Rating of “Moderate Buy” from Brokerages

Nyxoah S.A. (NASDAQ:NYXH) has been given a consensus recommendation of “Moderate Buy” by the six brokerages that are covering the company, MarketBeat reports. One research analyst has rated the stock with a hold rating and five have given a buy rating to the company. The average 12-month target price among brokerages that have updated their coverage on the stock in the last year is $20.60.

Several research analysts recently weighed in on the stock. Oppenheimer boosted their price target on shares of Nyxoah from $17.00 to $20.00 and gave the stock an “outperform” rating in a report on Thursday, March 14th. HC Wainwright reaffirmed a “buy” rating and issued a $22.00 price objective (up previously from $18.00) on shares of Nyxoah in a research report on Wednesday, March 20th. Piper Sandler lifted their price objective on shares of Nyxoah from $15.00 to $20.00 and gave the stock an “overweight” rating in a research report on Wednesday, March 6th. Stifel Nicolaus lifted their price objective on shares of Nyxoah from $20.00 to $27.00 and gave the stock a “buy” rating in a research report on Wednesday, March 20th. Finally, Cantor Fitzgerald lifted their price objective on shares of Nyxoah from $10.00 to $14.00 and gave the stock an “overweight” rating in a research report on Friday, February 9th.

Institutional Trading of Nyxoah

Hedge funds and other institutional investors have recently modified their holdings of the business. Millennium Management LLC bought a new stake in shares of Nyxoah in the fourth quarter valued at approximately $51,000. ExodusPoint Capital Management LP bought a new stake in shares of Nyxoah in the first quarter valued at approximately $97,000. Sei Investments Co. bought a new stake in shares of Nyxoah in the second quarter valued at approximately $265,000. JPMorgan Chase & Co. bought a new stake in shares of Nyxoah in the first quarter valued at approximately $965,000. Finally, AXA S.A. raised its position in shares of Nyxoah by 1.4% in the first quarter. AXA S.A. now owns 217,000 shares of the company’s stock valued at $1,621,000 after purchasing an additional 3,000 shares during the period.

Nyxoah Stock Down 10.4 %

Nyxoah stock opened at $9.72 on Friday. Nyxoah has a fifty-two week low of $4.00 and a fifty-two week high of $20.00. The firm’s 50-day simple moving average is $13.84 and its 200 day simple moving average is $8.52. The company has a debt-to-equity ratio of 0.12, a quick ratio of 4.50 and a current ratio of 4.73.

Nyxoah (NASDAQ:NYXH) last released its quarterly earnings results on Tuesday, March 5th. The company reported ($0.41) earnings per share for the quarter, hitting the consensus estimate of ($0.41). Nyxoah had a negative net margin of 993.28% and a negative return on equity of 38.58%. The business had revenue of $1.96 million for the quarter, compared to analysts’ expectations of $2.01 million. Equities analysts forecast that Nyxoah will post -1.78 EPS for the current fiscal year.

About Nyxoah

Nyxoah SA, a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions. The company's lead solution comprises Genio system, a CE-Marked, patient-centric, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea.